Prices delayed by at least 15 minutes | Print


Quest Diagnostics (DGX)

Common Stock
Sell: $130.21|Buy: $135|Change: 2.05 (1.56%)

Open 

$131.18


Previous close 

$131.06


Trade high 

$133.41


Volume 

888,001


Year high 

$148.62


Year low 

$119.59


Dividend yield 

2.17%


Market capitalisation 

$14.74 bn


P/E ratio 

17.50


ISIN 

US74834L1008


This share can be held in a Dealing accountISALifetime ISAJISASIPP

Share price

Dividends

PreviousLatest
Record date17/01/202408/04/2024
Ex-dividend date16/01/202405/04/2024
Payment date31/01/202422/04/2024
Amount$0.71$0.75

Performance 31/03/2024

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
Quest Diagnostics+ 1.56
More...

Company profile

Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.

Sector 

Healthcare


AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2024 AJ Bell. All rights reserved.